About Us
Task Applied Science (TASK) was founded in 2005 by Prof. Andreas Diacon to accelerate the development and evaluation of novel antituberculosis drugs. TASK has completed several important projects in the last five years and contributed significantly to moving forward of the entire scientific field, culminating in a publication in the reputed New England Journal of Medicine*. TASK mainly collaborates with international NGOs, government related consortia, academic centers and pharmaceutical companies on various drug development projects.
TASK now employs 50 staff members and has invested in laboratory capacity and in a network of clinical sites in underprivileged areas in Cape Town.
* Diacon AH, et al .The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis. NEJM 2009;360:2397-2405.
